Trials / Completed
CompletedNCT01241695
Safety, Acceptability and Efficacy of a Long-term Intervention With a Diabetes-specific Low-carbohydrate, High-mono-unsaturated Fatty Acid Containing Oral Nutritional Supplement on Glycaemic Control in Type 2 Diabetic Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Fresenius Kabi · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine the safety, acceptability and the efficacy of a 12-week intervention with a diabetes-specific oral nutritional supplement on glycaemic control in type 2 diabetic patients with or at risk of malnutrition
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Oral nutritional supplement, food for special medical purposes | 2 servings of 200 ml per day, treatment period: 12 weeks |
| DIETARY_SUPPLEMENT | Oral nutritional supplement, food for special medical purposes | 2 servings of 200 ml per day, treatment period: 12 weeks |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2010-11-16
- Last updated
- 2012-07-02
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01241695. Inclusion in this directory is not an endorsement.